Strekin AG
PrivateLast Round
Series A
Sep 3, 2019
Total Funding Raised
$13.16M
Company Overview
Strekin AG is a clinical-stage biopharmaceutical company that develops novel therapeutics for diseases involving cell stress-related inflammatory pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strekin AG Comparables
Compare Strekin AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acousia Therapeutics GmbH | 88% | |
| AudioCure Pharma | 85% | |
| Sound Pharmaceuticals, Inc. | 85% |
Strekin AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 3, 2019 | ||||
| Seed | May 31, 2017 | ||||
| Seed | Mar 1, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 1052% MoM, from 211 to 2.4K.
- May 2, 2025
Monthly visitors grew 336% MoM, from 211 to 919.
Strekin AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Strekin AG's valuation, stock price, and market status.
Is Strekin AG a public or private company?
Strekin AG is a private company.
What is the current stock price of Strekin AG?
Strekin AG is a private company with no public stock price. No recent secondary market data is available.
How much is Strekin AG worth (valuation)?
Valuation information for Strekin AG is not publicly available.
Can I buy Strekin AG stock?
Strekin AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Strekin AG's last funding round?
Strekin AG's most recent funding round was Series A on September 3, 2019.
Who are the main investors in Strekin AG?
Investor information for Strekin AG is not publicly disclosed.
Will Strekin AG IPO soon?
No public IPO plans have been announced for Strekin AG.
How can I track Strekin AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Strekin AG's secondary market activity and sign up for updates.